x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The IMID Forum

The Immune-Mediated Inflammatory Disease Forum

Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.

education

All Episodes

00:11:28

Perspectives in Inflammation - Prof Leonard Calabrese

The IMID Forum ·

2020/09/11

Vice Chair of the Cleveland Clinic's Department of Rheumatic and Immunologic Diseases in Cleveland, Ohio. In this podcast, Prof Leonard Calabrese discusses his interest in rheumatology, his work considering the interface between rheumatic diseases and infection, and the significance of herpes zoster in inflammatory disease. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests,

en

00:22:35

Rheumatology Author Vibeke Strand: Upadacitinib...

The IMID Forum ·

2020/08/27

Vibeke Strand, Adjunct Clinical Professor in the Division of Immunology and Rheumatology in the Stanford University School of Medicine. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Vibeke Strand discusses the safety and efficacy of upadacitinib monotherapy in RA.

en

00:28:06

Perspectives in Inflammation - Dr Enrique Soriano

The IMID Forum ·

2020/08/26

Chair of Department of Rheumatology in the Hospital Italiano, Buenos Aires, Argentina. In this podcast, Dr Soriano discusses his interest in Rheumatology, and his current research collaboration across Argentina.

en

00:07:58

Discussing Rheumatology: JAK Inhibitor Monotherapy in RA

The IMID Forum ·

2020/08/21

Prof Iain McInnes discusses the safety and efficacy of baricitinib and upadacitinib as monotherapy treatments in RA. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:21:11

Rheumatology Author Roy Fleischmann: Baricitinib...

The IMID Forum ·

2020/08/21

Professor Roy Fleischmann from the University of Texas Southwestern Medical Center, Dallas. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Roy Fleischmann discusses the safety and efficacy of long-term baricitinib monotherapy in RA.

en

00:22:31

Rheumatology Author Kosuke Ebina: Drug Retention

The IMID Forum ·

2020/08/06

Prof Kosuke Ebina from the University of Osaka, Japan. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Kosuke Ebina discusses drug retention of 7 biologics and tofacitinib in biologics-naïve and biologics-switched patients with RA using real-world data from the ANSWER registry.

en

00:09:20

Perspectives in Inflammation - Prof Chris Ritchlin

The IMID Forum ·

2020/08/06

Chief of the Allergy Immunology and Rheumatology Division and Executive Committee Member of the Center for Musculoskeletal Research. In this podcast, Prof Chris Ritchlin discusses how he became involved in rheumatology. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

en

00:22:55

Rheumatology Author Georg Schett: SARS-CoV-2

The IMID Forum ·

2020/07/31

Professor Georg Schett from the University of Erlangen-Nuremberg. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Georg Schett discusses SARS-CoV-2 seroconversion in patients with immune-mediated inflammatory diseases receiving cytokine inhibitors.

en

00:07:21

Discussing Rheumatology: PsA and Drug Retention

The IMID Forum ·

2020/07/22

Prof Iain McInnes discusses the long term safety of tofacitinib in PsA and drug retention. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:17:25

Perspectives in Inflammation – Prof Maurizio Cutolo

The IMID Forum ·

2020/07/07

Past president of EULAR, incoming president of ILAR and the Associate Editor of the Journal of Clinical and Experimental Rheumatology. In this podcast, Prof Maurizio Cutolo discusses circadian rhythms in inflammation alongside Prof Kevin Winthrop from Oregon Health and Science University. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in

en

00:37:14

Perspectives in Inflammation - Prof Chris Buckley

The IMID Forum ·

2020/07/03

Kennedy Professor of Translational Rheumatology at the Universities of Birmingham and Oxford. In this podcast, Prof Chris Buckley discusses his contribution to A-TAP for which he received the prestigious Carol Nachman prize in 2020. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

en

00:20:26

Rheumatology Author Axel Finckh: Drug Maintenance

The IMID Forum ·

2020/06/26

Professor Axel Finckh from the Universirty of Geneva. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Axel Finckh discusses drug maintenacne in the Swiss population.

en

00:21:08

Rheumatology Author Prof Gerd Burmester: PsA & Hep B

The IMID Forum ·

2020/06/23

Professor Gerd Burmester from the Charité. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Gerd Burmester discusses the safety of tofacitinib in PsA and evaluates Hep B in baricitinib trials.

en

00:12:23

Rheumatology Author Dr Stanley Cohen: Fenebrutinib

The IMID Forum ·

2020/06/23

Dr Stanley Cohen from Southwestern Medical School. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Stanley Cohen discusses a phase 2 trial of BTK inhibitor, fenebrutinib.

en

00:08:05

Discussing Rheumatology: Baricitinib Safety and...

The IMID Forum ·

2020/06/22

Prof Iain McInnes discusses the safety profile and temporary interruption of baricitinib. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

en

00:43:39

Insights at EULAR 2020: Safety Of JAK Inhibitors

The IMID Forum ·

2020/06/17

Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on the safety of JAK inhibitors and features presentations from; Professor Leonard Calabrese, Professor Kevin Winthrop, Professor Iain McInnes and Professor Anja Strangfeld.

en

00:17:24

Insights at EULAR 2020: Basic Science

The IMID Forum ·

2020/06/17

Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great basic science abstracts from Professor Iain McInnes and Professor Thomas Dörner.

en

00:45:11

Insights at EULAR 2020: Clinical Data on JAK Inhibitors

The IMID Forum ·

2020/06/16

Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on JAK inhibitors featuring presentations from; Professor Maya Buch, Professor Paul Emery, Professor Roy Fleischmann, Professor Peter Nash and Dr Kim Lauper

en

00:32:40

Insights at EULAR 2020: PRO & Real World

The IMID Forum ·

2020/06/11

Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on patient reported outcomes and real-world data featuring presentations from; Professor Rieke Alten, Professor Vibeke Strand, Professor Axel Finckh, and Dr Kelly Gavigan.

en

00:32:28

Insights at EULAR 2020: Beyond RA

The IMID Forum ·

2020/06/11

Gain insight into the latest research presented at EULAR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition focuses on JAK inhibitors and emerging treatments in therapy areas beyond RA, featuring presentations from; Professor Peter Nash, Professor Xenofon Baraliakos, Professor Atul Deodhar, Professor David Isenberg.

en

389 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College